Company profile · Łódź, Poland

Mabion S.A.

CMO for Recombinant Proteins · Commercial biologics CDMO

Verified 14 Mar 2026 · 3 sources

CDMOBiologicsCommercial
PolandCDMOŁódź

Commercial biologics CDMO platform geared for recombinant protein and antibody manufacturing under GMP operating discipline.

Lead
Gregor Kawaletz (verified ↗)
Compliance
GMP-compliant biologics manufacturing
Last reviewed
14 Mar 2026 (4mo ago)
Scale
Commercial biologics CDMO
Capabilities
Recombinant Protein Manufacturing · CDMO Services · Novavax Partner Program Support
Founded
2007
Headcount
201-500
Editorial note

CMO for Recombinant Proteins

Commercial biologics CDMO platform geared for recombinant protein and antibody manufacturing under GMP operating discipline.

Related companies
Editorial note

Executing 2025-2030 ADC Expansion Strategy.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026

Verification details

Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Gregor Kawaletz

Chief Executive Officer and President of the Management Board

Check official leadership source
Full addressgen. Mariana Langiewicza 60, 95-050 Konstantynów Łódzki, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Mabion contact page naming the Konstantynów Łódzki headquarters and operating complex.

Open source
Operating profile

Commercial biologics CDMO

Łódź, Poland. CMO for Recombinant Proteins. Review completed on 14 Mar 2026.

2026 technical specializationCMO for Recombinant Proteins
Core capabilities
Recombinant Protein ManufacturingCDMO ServicesNovavax Partner Program Support
Governance

Polish and EU pharmaceutical oversight

GMP-compliant biologics manufacturing

Capabilities

Recombinant Protein Manufacturing
CDMO Services
Novavax Partner Program Support

Sources

The official sources used to verify this profile.

Leadership evidenceMabion leadership page.Source origin: mabion.euOpen source
Supporting evidenceMabion DCAT Week 2026 event page listing Gregor Kawaletz as CEO and President of the Management Board.Source origin: mabion.euOpen source
Physical-site evidenceOfficial Mabion contact page naming the Konstantynów Łódzki headquarters and operating complex.Source origin: mabion.euOpen source

Infrastructure

Equipment detail not disclosed in the current record.

Certifications

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026

Review log

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.

Frequently asked questions

Where is Mabion S.A. located?
Mabion S.A. operates from gen. Mariana Langiewicza 60, 95-050 Konstantynów Łódzki, Poland, Łódź, Poland.
Who runs Mabion S.A.?
Mabion S.A. is led by Gregor Kawaletz, Chief Executive Officer and President of the Management Board. Verified 14 Mar 2026.
What certifications does Mabion S.A. hold?
Mabion S.A. is documented under GMP-compliant biologics manufacturing.
What does Mabion S.A. do?
Commercial biologics CDMO platform geared for recombinant protein and antibody manufacturing under GMP operating discipline. Core capabilities: Recombinant Protein Manufacturing, CDMO Services, Novavax Partner Program Support.
Editorial context

Related technical briefs

Briefs that name Łódź as a covered market or city.